Literature DB >> 23144315

Impact of site-specific phosphorylation of protein kinase A sites Ser23 and Ser24 of cardiac troponin I in human cardiomyocytes.

Paul J M Wijnker1, D Brian Foster, Allison L Tsao, Aisha H Frazier, Cristobal G dos Remedios, Anne M Murphy, Ger J M Stienen, Jolanda van der Velden.   

Abstract

PKA-mediated phosphorylation of contractile proteins upon β-adrenergic stimulation plays an important role in the regulation of cardiac performance. Phosphorylation of the PKA sites (Ser(23)/Ser(24)) of cardiac troponin (cTn)I results in a decrease in myofilament Ca(2+) sensitivity and an increase in the rate of relaxation. However, the relation between the level of phosphorylation of the sites and the functional effects in the human myocardium is unknown. Therefore, site-directed mutagenesis was used to study the effects of phosphorylation at Ser(23) and Ser(24) of cTnI on myofilament function in human cardiac tissue. Serines were replaced by aspartic acid (D) or alanine (A) to mimic phosphorylation and dephosphorylation, respectively. cTnI-DD mimics both sites phosphorylated, cTnI-AD mimics Ser(23) unphosphorylated and Ser(24) phosphorylated, cTnI-DA mimics Ser(23) phosphorylated and Ser(24) unphosphorylated, and cTnI-AA mimics both sites unphosphorylated. Force development was measured at various Ca(2+) concentrations in permeabilized cardiomyocytes in which the endogenous troponin complex was exchanged with these recombinant human troponin complexes. In donor cardiomyocytes, myofilament Ca(2+) sensitivity (pCa(50)) was significantly lower in cTnI-DD (pCa(50): 5.39 ± 0.01) compared with cTnI-AA (pCa(50): 5.50 ± 0.01), cTnI-AD (pCa(50): 5.48 ± 0.01), and cTnI-DA (pCa(50): 5.51 ± 0.01) at ~70% cTn exchange. No effects were observed on the rate of tension redevelopment. In cardiomyocytes from idiopathic dilated cardiomyopathic tissue, a linear decline in pCa(50) with cTnI-DD content was observed, saturating at ~55% bisphosphorylation. Our data suggest that in the human myocardium, phosphorylation of both PKA sites on cTnI is required to reduce myofilament Ca(2+) sensitivity, which is maximal at ~55% bisphosphorylated cTnI. The implications for in vivo cardiac function in health and disease are detailed in the DISCUSSION in this article.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23144315      PMCID: PMC3543672          DOI: 10.1152/ajpheart.00498.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  52 in total

1.  Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart.

Authors:  R J Solaro; A J Moir; S V Perry
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

2.  Acute modulation of PP2a and troponin I phosphorylation in ventricular myocytes: studies with a novel PP2a peptide inhibitor.

Authors:  Prajwal A Deshmukh; Bradford C Blunt; Polly A Hofmann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-09-29       Impact factor: 4.733

3.  The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin.

Authors:  S P Robertson; J D Johnson; M J Holroyde; E G Kranias; J D Potter; R J Solaro
Journal:  J Biol Chem       Date:  1982-01-10       Impact factor: 5.157

4.  The use of phosphate-affinity SDS-PAGE to measure the cardiac troponin I phosphorylation site distribution in human heart muscle.

Authors:  Andrew E Messer; Clare E Gallon; William J McKenna; Cristobal G Dos Remedios; Steven B Marston
Journal:  Proteomics Clin Appl       Date:  2009-10-13       Impact factor: 3.494

5.  Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites.

Authors:  Eiki Takimoto; David G Soergel; Paul M L Janssen; Linda B Stull; David A Kass; Anne M Murphy
Journal:  Circ Res       Date:  2004-01-15       Impact factor: 17.367

6.  Protein kinase A does not alter economy of force maintenance in skinned rat cardiac trabeculae.

Authors:  P P de Tombe; G J Stienen
Journal:  Circ Res       Date:  1995-05       Impact factor: 17.367

7.  Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C.

Authors:  R Zhang; J Zhao; J D Potter
Journal:  J Biol Chem       Date:  1995-12-22       Impact factor: 5.157

8.  The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.

Authors:  J van der Velden; Z Papp; N M Boontje; R Zaremba; J W de Jong; P M L Janssen; G Hasenfuss; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-02       Impact factor: 10.787

9.  Stepwise subunit interaction changes by mono- and bisphosphorylation of cardiac troponin I.

Authors:  S U Reiffert; K Jaquet; L M Heilmeyer; F W Herberg
Journal:  Biochemistry       Date:  1998-09-29       Impact factor: 3.162

10.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

View more
  31 in total

1.  Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation.

Authors:  Mohit Kumar; Suresh Govindan; Mengjie Zhang; Ramzi J Khairallah; Jody L Martin; Sakthivel Sadayappan; Pieter P de Tombe
Journal:  J Biol Chem       Date:  2015-10-09       Impact factor: 5.157

2.  Cardiac troponin I phosphorylation and the force-length relationship.

Authors:  Yael Yaniv
Journal:  J Physiol       Date:  2013-12-15       Impact factor: 5.182

Review 3.  Targeting the sarcomere to correct muscle function.

Authors:  Peter M Hwang; Brian D Sykes
Journal:  Nat Rev Drug Discov       Date:  2015-04-17       Impact factor: 84.694

4.  Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.

Authors:  Hussam E Salhi; Shane D Walton; Nathan C Hassel; Elizabeth A Brundage; Pieter P de Tombe; Paul M L Janssen; Jonathan P Davis; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2014-09-22       Impact factor: 5.000

5.  Length dependence of striated muscle force generation is controlled by phosphorylation of cTnI at serines 23/24.

Authors:  Laurin M Hanft; Brandon J Biesiadecki; Kerry S McDonald
Journal:  J Physiol       Date:  2013-07-08       Impact factor: 5.182

6.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

7.  Long-Term Biased β-Arrestin Signaling Improves Cardiac Structure and Function in Dilated Cardiomyopathy.

Authors:  David M Ryba; Jieli Li; Conrad L Cowan; Brenda Russell; Beata M Wolska; R John Solaro
Journal:  Circulation       Date:  2017-01-19       Impact factor: 29.690

8.  Restrictive Cardiomyopathy Troponin I R145W Mutation Does Not Perturb Myofilament Length-dependent Activation in Human Cardiac Sarcomeres.

Authors:  Alexey V Dvornikov; Nikolai Smolin; Mengjie Zhang; Jody L Martin; Seth L Robia; Pieter P de Tombe
Journal:  J Biol Chem       Date:  2016-08-24       Impact factor: 5.157

9.  Length-dependent activation is modulated by cardiac troponin I bisphosphorylation at Ser23 and Ser24 but not by Thr143 phosphorylation.

Authors:  Paul J M Wijnker; Vasco Sequeira; D Brian Foster; Yuejin Li; Cristobal G Dos Remedios; Anne M Murphy; Ger J M Stienen; Jolanda van der Velden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-28       Impact factor: 4.733

10.  Phosphorylation of protein kinase C sites Ser42/44 decreases Ca(2+)-sensitivity and blunts enhanced length-dependent activation in response to protein kinase A in human cardiomyocytes.

Authors:  Paul J M Wijnker; Vasco Sequeira; E Rosalie Witjas-Paalberends; D Brian Foster; Cristobal G dos Remedios; Anne M Murphy; Ger J M Stienen; Jolanda van der Velden
Journal:  Arch Biochem Biophys       Date:  2014-05-09       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.